IrishAngels

IrishAngels is an early-stage venture firm based in Chicago, Illinois, founded in 2012. The firm focuses on investing in high-potential startups across the United States, specifically in sectors such as software, consumer products, and medical devices. The IrishAngels network comprises 225 investors, including prominent venture capital and private equity professionals, along with experienced entrepreneurs. This diverse group collaborates to identify and support innovative companies in their early stages, facilitating growth and development within the startup ecosystem.

Craig Chval

Senior Associate

Richard Conklin

Investor

Caroline Gash

Managing Director

John McNelis

Angel Investor

Past deals in Indiana

FloVision Solutions

Seed Round in 2021
FloWaste is a food analytic platform that optimizes supplier comparative analysis, meal performance, and food wastage. The platform also develops machine learning algorithms to detect food waste and offer recommendations to the user on how to reduce their "food-print" and save money. FloWaste was founded in 2020 and is headquartered in South Bend, Indiana, USA.

TayCo Brace

Seed Round in 2021
TayCo Brace is a medical device company that specializes in the production of a lightweight, custom-fit external ankle brace designed to aid individuals recovering from ankle injuries. This innovative brace serves as an alternative to traditional, bulky ankle supports and uncomfortable walking boots, allowing users to maintain their daily activities, including driving, working, and participating in sports. The design enhances stability, performance, and comfort, promoting immediate functional recovery while reducing the risk of further injuries caused by limb imbalance. Through its focused approach, TayCo Brace aims to improve the quality of life for those affected by ankle injuries.

Malomo

Seed Round in 2020
Malomo, Inc. is an information technology company based in Indianapolis, Indiana, that specializes in shipment marketing for e-commerce businesses. Established in 2018, Malomo has developed a platform that transforms the shipment tracking experience into a marketing channel, allowing e-commerce brands to enhance customer engagement and drive revenue. The platform facilitates communication by enabling brands to send tracking information and branded content directly to customers, creating a more personalized experience. By integrating with customers' e-commerce sites and shipping providers, Malomo helps businesses improve customer retention and loyalty while simplifying the tracking process.

Pattern89

Seed Round in 2020
Pattern89 Inc. develops a predictive marketing artificial intelligence platform for marketers and ad agencies to maximize digital and social media ad performance. Its tool identifies trends, automates campaign selection, drills analysis of data elements, optimizes campaign spending, and offers real time campaign performance and reporting. Pattern89 Inc. was formerly known as Quantifi, Inc. and changed its name to Pattern89 Inc. in April 2018. The company was incorporated in 2016 and is headquartered in Indianapolis, Indiana.

Pattern89

Seed Round in 2018
Pattern89 Inc. develops a predictive marketing artificial intelligence platform for marketers and ad agencies to maximize digital and social media ad performance. Its tool identifies trends, automates campaign selection, drills analysis of data elements, optimizes campaign spending, and offers real time campaign performance and reporting. Pattern89 Inc. was formerly known as Quantifi, Inc. and changed its name to Pattern89 Inc. in April 2018. The company was incorporated in 2016 and is headquartered in Indianapolis, Indiana.

Lucata

Convertible Note in 2018
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

MyCOI

Series A in 2018
myCOI provides a SaaS-based certificate of insurance (COI) management solutions in the United States. The company’s solutions specialize in pharmaceutical, construction, and municipal certificate management. Its Web-based solution enables businesses and municipalities to automate COI collection, compliance validation, and tracking. The company serves construction and development, property/tenant management, franchisee management, trucking, retail, pharmaceutical, hospital, and manufacturing industries, as well as public utilities, universities, financial institutes, and city and state governments. My COI, LLC was incorporated in 2009 and is based in Marion, Indiana.

AgenDx Biosciences

Seed Round in 2018
AgenDx is an early stage molecular diagnostics company developing a revolutionary cost-effective molecular diagnostics platform. Their novel technology allows simple molecular diagnostic lab-quality testing. With a quick sample-to-answer in minutes, their platform is positioned to transform where and how disease is detected and treated. Their platform accommodates a wide range of nucleic-acid based tests for infectious disease, cancer, and other chronic conditions including cardiovascular disease and arthritis. Their initial focus is to prove the AgenDx technology by developing tests for aiding physician’s treatment decisions for pancreatic cancer. Their platform is designed for operation by untrained users in clinical settings near the patient. The sample is collected and inserted into a disposable cartridge. A control system automates and runs the test. Clear results will be displayed and transmitted. Their proprietary system will accommodate any biological sample, including blood, saliva, and tissue.

Lucata

Series A in 2017
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Lucata

Series A in 2017
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Lucata

Convertible Note in 2017
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Lucata

Series A in 2016
Emu Technology is focused on developing innovative hardware and software solutions that enhance memory utilization and eliminate data bottlenecks in microprocessors. Founded in 2004 and headquartered in South Bend, Indiana, the company has established strategic partnerships with notable firms such as Graham Allen Partners, Aunalytics, Data Realty, and Qumulus Solutions. A key offering from Emu Technology is the next-generation Lucata computer architecture, which significantly accelerates graph analytics, allowing organizations to conduct high-performance, multi-hop analytics on vast databases with up to one trillion vertices. This architecture leverages patented migrating thread technology to scale unified memory and facilitates deeper data analysis using existing graph database software or custom solutions. Emu Technology's solutions are applicable across various sectors, including financial services, cybersecurity, healthcare, telecommunications, and government, thereby enabling organizations to harness the power of advanced analytics and machine learning.

Vennli

Seed Round in 2016
Vennli, Inc. offers a choice visualization analytics platform aimed at enhancing business decision-making through customer insights. Founded in 2013 and based in South Bend, Indiana, Vennli enables companies to understand how their customers make choices, allowing for swift and informed actions to drive growth. The platform integrates primary research with advanced technology and a proven customer strategy model, equipping brands to develop relevant messaging and content strategies that resonate with their target audiences. By revealing customer priorities and preferences, Vennli helps businesses optimize their marketing communications, ensuring that they deliver the right message at the right time, ultimately leading to improved conversion rates and a competitive advantage in the marketplace.

AgenDx Biosciences

Seed Round in 2016
AgenDx is an early stage molecular diagnostics company developing a revolutionary cost-effective molecular diagnostics platform. Their novel technology allows simple molecular diagnostic lab-quality testing. With a quick sample-to-answer in minutes, their platform is positioned to transform where and how disease is detected and treated. Their platform accommodates a wide range of nucleic-acid based tests for infectious disease, cancer, and other chronic conditions including cardiovascular disease and arthritis. Their initial focus is to prove the AgenDx technology by developing tests for aiding physician’s treatment decisions for pancreatic cancer. Their platform is designed for operation by untrained users in clinical settings near the patient. The sample is collected and inserted into a disposable cartridge. A control system automates and runs the test. Clear results will be displayed and transmitted. Their proprietary system will accommodate any biological sample, including blood, saliva, and tissue.

Vennli

Convertible Note in 2014
Vennli, Inc. offers a choice visualization analytics platform aimed at enhancing business decision-making through customer insights. Founded in 2013 and based in South Bend, Indiana, Vennli enables companies to understand how their customers make choices, allowing for swift and informed actions to drive growth. The platform integrates primary research with advanced technology and a proven customer strategy model, equipping brands to develop relevant messaging and content strategies that resonate with their target audiences. By revealing customer priorities and preferences, Vennli helps businesses optimize their marketing communications, ensuring that they deliver the right message at the right time, ultimately leading to improved conversion rates and a competitive advantage in the marketplace.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.